CN101391007B - 锯叶棕果实提取物软胶囊的制备方法 - Google Patents
锯叶棕果实提取物软胶囊的制备方法 Download PDFInfo
- Publication number
- CN101391007B CN101391007B CN2008101952942A CN200810195294A CN101391007B CN 101391007 B CN101391007 B CN 101391007B CN 2008101952942 A CN2008101952942 A CN 2008101952942A CN 200810195294 A CN200810195294 A CN 200810195294A CN 101391007 B CN101391007 B CN 101391007B
- Authority
- CN
- China
- Prior art keywords
- capsule
- weight portion
- fruit extract
- saw palmetto
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 60
- 238000002360 preparation method Methods 0.000 title claims abstract description 47
- 229940018044 saw palmetto fruit extract Drugs 0.000 title claims description 44
- 239000000463 material Substances 0.000 claims abstract description 56
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 44
- 239000002775 capsule Substances 0.000 claims abstract description 35
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 32
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 32
- 239000007962 solid dispersion Substances 0.000 claims abstract description 27
- 239000010018 saw palmetto extract Substances 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 7
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000000725 suspension Substances 0.000 claims description 19
- 238000003756 stirring Methods 0.000 claims description 18
- 108010010803 Gelatin Proteins 0.000 claims description 15
- 229920000159 gelatin Polymers 0.000 claims description 15
- 239000008273 gelatin Substances 0.000 claims description 15
- 235000019322 gelatine Nutrition 0.000 claims description 15
- 235000011852 gelatine desserts Nutrition 0.000 claims description 15
- 238000001035 drying Methods 0.000 claims description 9
- 230000004927 fusion Effects 0.000 claims description 9
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 8
- 239000007766 cera flava Substances 0.000 claims description 8
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 8
- 229950005770 hyprolose Drugs 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 7
- 241001597008 Nomeidae Species 0.000 claims description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 6
- 239000008158 vegetable oil Substances 0.000 claims description 6
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 9
- 239000003814 drug Substances 0.000 abstract description 7
- SYUXAJSOZXEFPP-UHFFFAOYSA-N glutin Natural products COc1c(O)cc2OC(=CC(=O)c2c1O)c3ccccc3OC4OC(CO)C(O)C(O)C4O SYUXAJSOZXEFPP-UHFFFAOYSA-N 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 14
- 238000005516 engineering process Methods 0.000 description 12
- 230000002159 abnormal effect Effects 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000007774 longterm Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 230000035943 smell Effects 0.000 description 7
- 239000000654 additive Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- MOZDKDIOPSPTBH-UHFFFAOYSA-N Benzyl parahydroxybenzoate Chemical compound C1=CC(O)=CC=C1C(=O)OCC1=CC=CC=C1 MOZDKDIOPSPTBH-UHFFFAOYSA-N 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 240000006661 Serenoa repens Species 0.000 description 3
- 235000005318 Serenoa repens Nutrition 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 2
- 102000001307 androgen receptors Human genes 0.000 description 2
- 108010080146 androgen receptors Proteins 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241000233788 Arecaceae Species 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- -1 flavone compound Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229930193551 sterin Natural products 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003815 supercritical carbon dioxide extraction Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
参数 | 市售样品 | 实施例1样品 |
Cmax(μg·L-1) | 2.68 | 2.72 |
t1/2(h) | 6.35 | 6.41 |
tmax(h) | 1.65 | 1.25 |
AUC0-24(mg·h·ml-1) | 8.12±0.15 | 8.08±0.21 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101952942A CN101391007B (zh) | 2008-11-10 | 2008-11-10 | 锯叶棕果实提取物软胶囊的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101952942A CN101391007B (zh) | 2008-11-10 | 2008-11-10 | 锯叶棕果实提取物软胶囊的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101391007A CN101391007A (zh) | 2009-03-25 |
CN101391007B true CN101391007B (zh) | 2011-03-23 |
Family
ID=40491648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101952942A Active CN101391007B (zh) | 2008-11-10 | 2008-11-10 | 锯叶棕果实提取物软胶囊的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101391007B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105748432A (zh) * | 2014-12-15 | 2016-07-13 | 蚌埠丰原涂山制药有限公司 | 一种非诺贝特软胶囊及其制备方法 |
CN105147635B (zh) * | 2015-10-22 | 2017-11-10 | 重庆天春科技有限公司 | 一种锯叶棕植酸派烯缓释片的制备方法 |
-
2008
- 2008-11-10 CN CN2008101952942A patent/CN101391007B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101391007A (zh) | 2009-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109568253A (zh) | 液体制剂 | |
JP5844954B2 (ja) | アリタソウの抽出物を含有する医薬組成物、それらの製造方法 | |
KR102231129B1 (ko) | 수면 장애 치료용 발레리안 뿌리 추출물 및 라벤더 오일의 조합물 | |
CN110680808B (zh) | 一种氨糖咀嚼片及其制备方法 | |
CN101391007B (zh) | 锯叶棕果实提取物软胶囊的制备方法 | |
CN101204392A (zh) | 可自微乳化的黄豆苷元口服制剂组合物及其制备方法 | |
JP2021518429A (ja) | 腸溶性ソフトゲルカプセル剤 | |
EP3888637A1 (en) | Lyophilized preparation for prostaglandin e1 methyl ester injection, preparation thereof and application thereof | |
CN1421241A (zh) | 一种治疗心脑血管疾病的复方丹参滴丸及其制备方法 | |
CN104306372B (zh) | 一种丁苯酞制剂组合物及其制备方法与用途 | |
CN1671359A (zh) | 胶冻状中草药组合物 | |
US8241682B2 (en) | Effects of Dichrostachys glomerata DG, Hypodaphnis zenkeri HZ, and Xylopia aethiopica XA on various cardiovascular risk factors and metabolic syndrome | |
JP2007527360A (ja) | 高脂血症治療のための相乗効果的医薬組成物 | |
CN101108252A (zh) | 环糊精和血竭的药物组合物及其制备方法 | |
KR100818091B1 (ko) | 자동 미셀화 약물송달시스템을 이용한 경구용플라보노리그난의 약학적 조성물 | |
CN100363018C (zh) | 金银花软胶囊制剂及其制备方法 | |
RU2423111C2 (ru) | ЭКСТРАКТЫ ПРИМЕНЯЕМОГО В КИТАЙСКОЙ МЕДИЦИНЕ РАСТЕНИЯ Chenopodium ambrosioides L., КОМПОЗИЦИИ, ВКЛЮЧАЮЩИЕ УПОМЯНУТЫЕ ЭКСТРАКТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ | |
JP7189873B2 (ja) | 粉末状固体組成物、その製造方法、製剤およびそれらの使用 | |
CN102552353A (zh) | 一种含有当归的中药组合物和制备方法 | |
CN100512849C (zh) | 知母总皂苷提取物用于制备心肌缺血产品的用途 | |
TWI660732B (zh) | 綠豆發酵萃取物用於製備促進傷口癒合的醫藥品的用途 | |
CN100450489C (zh) | 一种黄杨宁滴丸及其制备工艺 | |
JP2013199458A (ja) | カプセル製剤 | |
Vedhachalam et al. | A review of phytochemistry, medicinal uses and pharmacological actions of shigru | |
CN100488503C (zh) | 一种治疗心脑血管疾病的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU SHENLONG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: HU CHUANLIANG Effective date: 20150910 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150910 Address after: 224200 Jiangsu Province, Yancheng City Dongtai City Ho duo Road No. 18 Patentee after: Jiangsu Shenlong Pharmaceutical Co., Ltd. Address before: 210008 Jiangsu Honghui Pharmaceutical Co., Ltd., 6 West Beijing Road, Jiangsu, Nanjing Patentee before: Hu Chuanliang |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 224200 Jiangsu Province, Yancheng City Dongtai City Ho duo Road No. 18 Patentee after: Jiangsu Shenlong pharmaceutical Limited by Share Ltd Address before: 224200 Jiangsu Province, Yancheng City Dongtai City Ho duo Road No. 18 Patentee before: Jiangsu Shenlong Pharmaceutical Co., Ltd. |
|
CP03 | Change of name, title or address |
Address after: No.15 Weiba Road, Dongtai City, Yancheng City, Jiangsu Province 224200 Patentee after: JIANGSU SHENLONG PHARMACEUTICAL Co.,Ltd. Address before: 224200, No. 18 North Road, Dongtai, Jiangsu, Yancheng City Patentee before: JIANGSU SHENLONG PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address |